SCIOS NOVA INC
10-Q/A, 1995-05-05
PHARMACEUTICAL PREPARATIONS
Previous: SCIOS NOVA INC, 8-K, 1995-05-05
Next: PARKWAY CO/TX, SC 13E3/A, 1995-05-05



<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                   FORM 10-Q/A
                                (AMENDMENT NO. 1)

(Mark One)
/X/    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

       For the quarterly period ended March 31, 1995

/ /    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

       For the transition period from __________ to __________

                       Commission File Number:  0-11749

                                   SCIOS NOVA INC.
          -------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)


                      DELAWARE                        95-3701481
          -------------------------------------------------------------
          (State or Other Jurisdiction of         (IRS Employer
          Incorporation or Organization)          Identification No.)


          2450 BAYSHORE PARKWAY, MOUNTAIN VIEW, CALIFORNIA      94043
          -------------------------------------------------------------
          (Address of Principal Executive Offices)          (Zip Code)

          Registrant's Telephone Number, Including Area Code:     415-966-1550


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.

                              Yes    X    No
                                  -------    -------

The number of shares outstanding of Registrant's Common Stock, $.001 par value,
on March 31, 1995 was 35,496,030.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

<PAGE>

1.   Part II, Item 6(b) is hereby amended in its entirety by adding the
following language:

     (b)  Reports on Form 8-K

          Report on Form 8-K dated January 19, 1995 (pursuant to Item 5)
          regarding the Company's collaboration with Genentech, Inc.









Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                        SCIOS NOVA INC.


Date:   May 5, 1995                     /s/ JOHN H. NEWMAN
                                        ---------------------------------------
                                        John H. Newman
                                        Vice President of Legal Affairs


                                        2




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission